5 Must-Read Analyst Questions From Pediatrix Medical Group's Q3 Earnings Call [Yahoo! Finance]
Mednax, Inc. (MD)
Last mednax, inc. earnings: 2/20 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
mednax.com/investors
Company Research
Source: Yahoo! Finance
Management cited robust revenue cycle management, favorable payer mix, and increased patient acuity as key drivers behind the results. CEO Mark Ordan highlighted the company's clinical leadership and deep research activity, stating, “We have massive clinical scale,” and emphasized the unique breadth of Pediatrix's neonatology and maternal-fetal medicine network. Additionally, portfolio restructuring and expense control played significant roles in boosting margins and cash flow. Is now the time to buy MD? Find out in our full research report (it's free for active Edge members). Pediatrix Medical Group (MD) Q3 CY2025 Highlights: Revenue: $492.9 million vs analyst estimates of $477.7 million (3.6% year-on-year decline, 3.2% beat) Adjusted EPS: $0.67 vs analyst estimates of $0.47 (44.2% beat) Adjusted EBITDA: $87.32 million vs analyst estimates of $64.72 million (17.7% margin, 34.9% beat) EBITDA guidance for the full year is $280 million at the midpoint, above analyst estimate
Show less
Read more
Impact Snapshot
Event Time:
MD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MD alerts
High impacting Mednax, Inc. news events
Weekly update
A roundup of the hottest topics
MD
News
- Pediatrix Medical Group (NYSE:MD) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- Pediatrix Medical Group (MD) Delivers Higher Q3 Earnings Despite Sales Dip—Is Profitability Now the Focus? [Yahoo! Finance]Yahoo! Finance
- Pediatrix Medical Group (NYSE:MD) had its price target raised by analysts at Truist Financial Corporation from $17.00 to $24.00. They now have a "hold" rating on the stock.MarketBeat
- Pediatrix Medical Group (NYSE:MD) had its "neutral" rating reaffirmed by analysts at UBS Group AG.MarketBeat
MD
Earnings
- 11/3/25 - Beat
MD
Sec Filings
- 11/19/25 - Form 4
- 11/17/25 - Form 144
- 11/10/25 - Form 4
- MD's page on the SEC website